(VIANEWS) – The Market ended the session with AFFLUENT MEDICAL (AFME.PA) rising 11.11% to €1.60 on Thursday while CAC 40 jumped 0.69% to €7,284.22.
AFFLUENT MEDICAL’s last close was €1.44, 70.85% under its 52-week high of €4.94.
About AFFLUENT MEDICAL
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
Earnings Per Share
As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.987.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.51%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AFFLUENT MEDICAL’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
AFFLUENT MEDICAL’s stock is valued at €1.60 at 21:30 EST, way under its 52-week high of €4.94 and way above its 52-week low of €1.40.
More news about AFFLUENT MEDICAL (AFME.PA).
